{"id":"W2560708148","doi":"10.1016/s1470-2045(16)30632-5","title":"Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Royal Victoria Hospital; Dalhousie University","funders":"Pharmacyclics","keywords":"Rituximab; Medicine; Ibrutinib; Internal medicine; Population; Waldenstrom macroglobulinemia; Oncology; Lymphoma; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003092271,0.001172639,0.002107235,0.0003743568,0.0003538103,0.001560047,0.0008498051,0.001313397,0.002296922],"category_scores_gemma":[0.001668175,0.000462825,0.002352491,0.0004735132,0.0008758156,0.001303175,0.0004639483,0.003300844,0.0007175041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001078582,"about_ca_system_score_gemma":0.0008352181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001059187,"about_ca_topic_score_gemma":0.003748472,"domain_scores_codex":[0.9992636,0.0003407871,0.00004153205,0.000108245,0.00007417996,0.0001715889],"domain_scores_gemma":[0.9992492,0.0002313537,0.0001901716,0.00007371247,0.00005015897,0.0002054471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8413655,0.004445545,0.006743586,0.002180753,0.006531575,0.0001557083,0.0003621824,0.001495164,0.008476986,0.0004310241,0.005388552,0.1224235],"study_design_scores_gemma":[0.9250557,0.05018561,0.01308796,0.0002275516,0.003145802,0.0002211829,0.000134166,0.0006978548,0.001041507,0.0003994657,0.005754333,0.00004870007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9598201,0.03080984,0.0005115864,0.001432638,0.0004485945,0.0009370641,0.001646505,0.0001274002,0.0042662],"genre_scores_gemma":[0.9823661,0.008863734,0.001095034,0.001972601,0.0003378785,0.0007442234,0.002710231,0.00003159866,0.001878626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003092271,"threshold_uncertainty_score":0.01635373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1097531342863321,"score_gpt":0.454956165901559,"score_spread":0.3452030316152269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}